Busi Sithole, joined HE2RO in 2009 and works as data capture and interviewer. Her duties include capturing data from clinic files, entering data into different electronic records systems and doing data cleaning. Busi has worked in a several studies which include the “Costs and Outcomes of paediatric ART in South Africa”, the “Nurses Initiated and Managed Antiretroviral Treatment for HIV/AIDS in South Africa (NIMART) study”, as well as the “RapIT Comparison Track 2 and RapIT NCD”. Prior to joining HE2RO Busi worked as a counsellor and as an assistant to a pharmacist at Charlotte Maxeke Hospital.
Retrospective Cost-Effectiveness Analysis for Nurse Initiated and Managed Antiretroviral Treatment for HIV/AIDS in South AfricaIn HIV/AIDS treatment programs in resource-constrained settings, one response to a shortage of doctors and other highly trained healthcare providers is “task-shifting” from doctors to less trained clinicians, such as nurses and community healthcare workers. In 2010, South Africa issued new guidelines for its antiretroviral treatment (ART) program to allow senior nurses to initiate and manage adult ART patients at primary health clinics. This policy, known as NIMART (Nurse Initiated and
Adverse Events of Treatment in a Decentralized Drug-Resistant Tuberculosis Clinic in Johannesburg, South AfricaThe overall aim of this study is to review adverse events of decentralized, ambulatory drug-resistant TB (DR-TB) among a high proportion of rifampicin monoresistant TB patients at an outpatient specialized clinic in Johannesburg, South Africa. The study is a retrospective study and differs in two significant ways from previous studies of DR-TB in South Africa. Firstly, a large proportion of the patients receiving decentralized care have rifampicin mono-resistant TB. All the previous studies
Costs and Outcomes Analysis of Decentralized, Deinstitutionalized Drug-Resistant Tuberculosis Management at a Johannesburg HospitalThe overall aim of this medical record review observational cohort study is to analyse the cost and outcomes of decentralized, deinstitutionalized drug-resistant TB (DR-TB) management at an outpatient specialized clinic in Johannesburg. In August 2011, the South African National Department of Health adopted guidelines regarding MDR-TB treatment, “Decentralised Management of Multidrug-Resistant Tuberculosis: A Policy Framework for South Africa.” These guidelines recommend that acid fast